Related Experiment Video

Updated: Jun 20, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Focal adhesion kinase as potential target for cancer therapy (Review)

Huifang Hao1, Yoshio Naomoto, Xiaohong Bao

  • 1Department of Gastroenterological Surgery, Transplant and Surgical Oncology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.

Oncology Reports
|September 30, 2009
PubMed

Insights

Focal adhesion kinase (FAK) is crucial for cell survival and proliferation. While inhibitors exist, further research is needed to understand FAK

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase involved in cell survival and proliferation.
  • FAK activity is linked to integrins and growth factor receptors, influencing cellular processes.
  • Nuclear FAK promotes proliferation and survival via FERM domain-enhanced p53 degradation.

Purpose of the Study:

  • To elucidate the detailed mechanisms of FAK's role in tumor cell generation and progression.
  • To highlight the need for further investigation into FAK's function in cancer biology.
  • To address limitations of current FAK inhibitors, including specificity and resistance.

Main Methods:

  • Review of existing literature on FAK function and its role in normal and cancer cells.
  • Analysis of studies involving small molecule inhibitors of FAK (PF-573,228; PF-562,271; NVP-226).
  • Identification of knowledge gaps regarding FAK's precise mechanisms in tumorigenesis.

Main Results:

  • FAK plays a critical role in both normal and cancer cell biological processes.
  • Existing small molecule inhibitors show potential for cancer therapy but have limitations.
  • The precise mechanisms of FAK in tumor development and progression require further exploration.

Conclusions:

  • FAK is a significant factor in cancer cell biology and a potential therapeutic target.
  • Further research is essential to fully understand FAK's role and develop effective inhibitors.
  • Development of novel FAK inhibitors with improved specificity and reduced resistance is necessary.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...